Antithrombin use and mortality in patients with stage IV solid tumor-associated disseminated intravascular coagulation: a nationwide observational study in Japan
Abstract Background Terminal-stage solid tumors are one of the main causes of disseminated intravascular coagulation (DIC); effective therapeutic strategies are therefore warranted. This study aimed to investigate the association between mortality and antithrombin therapy in patients with stage IV s...
Main Authors: | Kohei Taniguchi, Hiroyuki Ohbe, Kazuma Yamakawa, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-09-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-020-07375-2 |
Similar Items
-
Effects of combination therapy of antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis
by: Takaaki Totoki, et al.
Published: (2024-01-01) -
Effect of Antithrombin III Administration on the Prognosis of Severe Trauma Patients with Disseminated Intravascular Coagulation
by: Jae Sik Chung, et al.
Published: (2023-05-01) -
Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation
by: Toshiaki Iba, et al.
Published: (2017-11-01) -
Association of antithrombin with development of trauma-induced disseminated intravascular coagulation and outcomes
by: Takeshi Wada, et al.
Published: (2022-12-01) -
Anticoagulant therapies against sepsis‐induced disseminated intravascular coagulation
by: Yutaka Umemura, et al.
Published: (2023-01-01)